Will Curis' TakeAim Trials Hit The Mark?

Curis Inc. (CRIS), a biotechnology company developing novel therapies for slowing or preventing the progression of cancer and prolonging life, has several important clinical trial milestones lined up for the end of this year.

from RTT - Top Story https://ift.tt/XDCvVkn
via IFTTT